Erratum: Corrigendum to “Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndrome” (Journal of Neuroimmunology (2015) 286 (86–92)(S0165572815300096)(10.1016/j.jneuroim.2015.07.007));Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndrome

Journal of Neuroimmunology

Volumn 286, Issue , 2015, Pages 86-92

  Panzer, Jessica A ^a,b   Anand, Ronan ^c   Dalmau, Josep ^b,d   Lynch, David R ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

Autoantibodies; Brainstem neurons; Cerebellar neurons; Opsoclonus myoclonus ataxia syndrome; Paraneoplastic neurological syndrome

Indexed keywords

ANTIGEN; AUTOANTIBODY; AUTOANTIGEN; DLGH4 PROTEIN, MOUSE; ELAV PROTEIN; GUANYLATE KINASE; MEMBRANE ANTIGEN; MEMBRANE PROTEIN;

ADOLESCENT; ADULT; AGED; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN BINDING; ANTIGEN DETECTION; ARTICLE; AUTOIMMUNITY; CELL SURFACE; CHILD; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DENDRITIC CELL; DISEASE ASSOCIATION; EMBRYO; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; MALE; MIDDLE AGED; MOUSE; NONHUMAN; OPSOCLONUS MYOCLONUS SYNDROME; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; AGE; ANIMAL; ANIMAL EMBRYO; BLOOD; BRAIN STEM; CELL CULTURE; CEREBELLUM; CEREBROSPINAL FLUID; CYTOLOGY; DENDRITE; DRUG EFFECTS; IMMUNOLOGY; INFANT; METABOLISM; NERVE CELL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, SURFACE; AUTOANTIBODIES; BRAIN STEM; CELLS, CULTURED; CEREBELLUM; CHILD; CHILD, PRESCHOOL; DENDRITES; ELAV PROTEINS; EMBRYO, MAMMALIAN; GUANYLATE KINASE; HUMANS; INFANT; MEMBRANE PROTEINS; MICE; MIDDLE AGED; NEURONS; OPSOCLONUS-MYOCLONUS SYNDROME; RATS; YOUNG ADULT;

EID: 84939549943     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2016.05.001     Document Type: Erratum

References (30)

1. Ances B.M., Vitaliani R., Taylor R.a., Liebeskind D.S., Voloschin A., Houghton D.J., Galetta S.L., Dichter M., Alavi A., Rosenfeld M.R., Dalmau J. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 2005, 128:1764-1777. 10.1093/brain/awh526.
2. Antunes N., Khakoo Y., Matthay K., Seeger R., Stram D., Gerstner E., Abrey L., Dalmau J. Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus. J. Pediatr. Hematol. Oncol. 2000, 22:315-320.
3. Culturing Nerve Cells 1998, (Bradford). 2nd ed. G. Banker, K. Goslin (Eds.).
4. Bataller L., Rosenfeld M.R., Graus F., Vilchez J.J., Cheung N.K.V., Dalmau J. Autoantigen diversity in the opsoclonus-myoclonus syndrome. Ann. Neurol. 2003, 53:347-353. 10.1002/ana.10462.
5. Bien C.G., Vincent A., Barnett M.H., Becker A.J., Blümcke I., Graus F., Jellinger K.a., Reuss D.E., Ribalta T., Schlegel J., Sutton I., Lassmann H., Bauer J. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 2012, 135:1622-1638. 10.1093/brain/aws082.
6. Blaes F., Fühlhuber V., Korfei M., Tschernatsch M., Behnisch W., Rostasy K., Hero B., Kaps M., Preissner K.T. Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome. Ann. Neurol. 2005, 58:313-317. 10.1002/ana.20539.
7. Braxton D.B., Williams M., Kamali D., Chin S., Liem R., Latov N. Specificity of human anti-neurofilament autoantibodies. J. Neuroimmunol. 1989, 21:193-203. 10.1016/0165-5728(89)90175-6.
8. Buchhalter J.R., Dichter M.a. Electrophysiological comparison of pyramidal and stellate nonpyramidal neurons in dissociated cell culture of rat hippocampus. Brain Res. Bull. 1991, 26:333-338. 10.1016/0361-9230(91)90003-3.
9. Catsman-Berrevoets C.E., Aarsen F.K., Van Hemsbergen M.L.C., Van Noesel M.M., Hakvoort-Cammel F.G.A.J., Van Den Heuvel-Eibrink M.M. Improvement of neurological status and quality of life in children with opsoclonus myoclonus syndrome at long-term follow-up. Pediatr. Blood Cancer 2009, 53:1048-1053.
10. Dalmau J., Tüzün E., Wu H., Masjuan J., Rossi J.E., Voloschin A., Baehring J.M., Shimazaki H., Koide R., King D., Mason W., Sansing L.H., Dichter M.a., Rosenfeld M.R., Lynch D.R. Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann. Neurol. 2007, 61:25-36. 10.1002/ana.21050.
11. Dalmau J., Gleichman A.J., Hughes E.G., Rossi J.E., Peng X., Lai M., Dessain S.K., Rosenfeld M.R., Balice-Gordon R., Lynch D.R. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008, 7:1091-1098. 10.1016/S1474-4422(08)70224-2.
12. De Grandis E., Parodi S., Conte M., Angelini P., Battaglia F., Gandolfo C., Pessagno a, Pistoia V., Mitchell W.G., Pike M., Haupt R., Veneselli E. Long-term follow-up of neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome. Neuropediatrics 2009, 40:103-111. 10.1055/s-0029-1237723.
13. Digre K.B. Opsoclonus in adults. Report of three cases and review of the literature. Arch. Neurol. 1986, 43:1165-1175. 10.1001/archneur.1986.00520110055016.
14. Höftberger R., Titulaer M.J., Sabater L., Dome B., Rózsás A., Hegedus B., Hoda M.A., Laszlo V., Ankersmit H.J., Harms L., Boyero S., De Felipe A., Saiz A., Dalmau J., Graus F. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology 2013, 81:1500-1506. 10.1212/WNL.0b013e3182a9585f.
15. Kilgo G., Schwartze G. Opsoclonus. Update on clinical and pathologic associations. J. Clin. Neuroophthalmol. 1984, 4:109-113.
16. Kim J.S., Choi K.D., Oh S.Y., Jeong S.H., Oh Y.M., Kim H.J., Park S.H., Ahn J.Y. Double saccadic pulses and macrosaccadic oscillations from a focal brainstem lesion. J. Neurol. Sci. 2007, 263:118-123. 10.1016/j.jns.2007.07.003.
17. Kinsbourne M. Myoclonic encephalopathy of infants. J. Neurol. Neurosurg. Psychiatry 1962, 25:271-276.
18. Korfei M., Fühlhuber V., Schmidt-Wöll T., Kaps M., Preissner K.T., Blaes F. Functional characterisation of autoantibodies from patients with pediatric opsoclonus-myoclonus-syndrome. J. Neuroimmunol. 2005, 170:150-157. 10.1016/j.jneuroim.2005.08.018.
19. Lai M., Hughes E.G., Peng X., Zhou L., Gleichman A.J., Shu H., Matà S., Kremens D., Vitaliani R., Geschwind M.D., Bataller L., Kalb R.G., Davis R., Graus F., Lynch D.R., Balice-Gordon R., Dalmau J. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann. Neurol. 2009, 65:424-434. 10.1002/ana.21589.
20. Lancaster E., Lai M., Peng X., Hughes E., Constantinescu R., Raizer J., Friedman D., Skeen M.B., Grisold W., Kimura A., Ohta K., Iizuka T., Guzman M., Graus F., Moss S.J., Balice-Gordon R., Dalmau J. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol. 2010, 9:67-76. 10.1016/S1474-4422(09)70324-2.
21. Lang B., Vincent A. Autoimmunity to ion-channels and other proteins in paraneoplastic disorders. Curr. Opin. Immunol. 1996, 8:865-871. 10.1016/S0952-7915(96)80017-3.
22. Luque F.a., Furneaux H.M., Ferziger R., Rosenblum M.K., Wray S.H., Schold S.C., Glantz M.J., Jaeckle K.a., Biran H., Lesser M. Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann. Neurol. 1991, 29:241-251. 10.1002/ana.410290303.
23. Noetzel M.J., Cawley L.P., James V.L., Minard B.J., Agrawal H.C. Anti-neurofilament protein antibodies in opsoclonus-myoclonus. J. Neuroimmunol. 1987, 15:137-145. 10.1016/0165-5728(87)90088-9.
24. Panzer J., Dalmau J. Movement disorders in paraneoplastic and autoimmune disease. Curr. Opin. Neurol. 2011, 24:346-353. 10.1097/WCO.0b013e328347b307.
25. Petit-Pedrol M., Armangue T., Peng X., Bataller L., Cellucci T., Davis R., McCracken L., Martinez-Hernandez E., Mason W.P., Kruer M.C., Ritacco D.G., Grisold W., Meaney B.F., Alcalá C., Sillevis-Smitt P., Titulaer M.J., Balice-Gordon R., Graus F., Dalmau J. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol. 2014, 13:276-286. 10.1016/S1474-4422(13)70299-0.
26. Ramat S., Leigh R.J., Zee D.S., Shaikh a.G., Optican L.M. Applying saccade models to account for oscillations. Prog. Brain Res. 2008, (Elsevier Masson SAS). 10.1016/S0079-6123(08)00616-X.
27. Smith J.H., Dhamija R., Moseley B.D., Sandroni P., Lucchinetti C.F., Lennon V.A., Kantarci O.H. N-methyl-d-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus. Arch. Neurol. 2011, 68:1069-1072.
28. Wong A. An update on opsoclonus. Curr. Opin. Neurol. 2007, 20:25-31. 10.1097/WCO.0b013e3280126b51.
29. Wong A.M.F., Musallam S., Tomlinson R.D., Shannon P., Sharpe J.A. Opsoclonus in three dimensions: oculographic, neuropathologic and modelling correlates. J. Neurol. Sci. 2001, 189:71-81.
30. Wu H.-Y., Hsu F.-C., Gleichman A.J., Baconguis I., Coulter D.a., Lynch D.R. Fyn-mediated phosphorylation of NR2B Tyr-1336 controls calpain-mediated NR2B cleavage in neurons and heterologous systems. J. Biol. Chem. 2007, 282:20075-20087. 10.1074/jbc.M700624200.